2026 Achievements

In Q3, CRN turned member priorities into policy progress, practical guidance and stronger platforms for the future. CRN secured a California labeling exemption, advanced federal drug-preclusion reform, helped companies navigate fast-changing requirements, strengthened science and public trust, and worked with association leaders to establish Vision 2030.

In Q2, CRN advanced science-based policy at Congressional meetings, provided practical guidance to our members on legal and regulatory emerging challenges, and represented our members' interests with policymakers, healthcare professionals, and other key stakeholders. This summary highlights the impact of CRN's work during the quarter.

In Q1, the Council for Responsible Nutrition team focused on issues that matter most to dietary supplement and functional food member companies: protecting the ability to bring products to market, calling for regulatory clarity, and promoting scientific credibility. CRN’s work this quarter reflects a clear priority—ensuring the industry can operate within a stable, science-based framework while continuing to innovate.